Effect of Tiotropium Plus Salmeterol vs. Fluticasone/Salmeterol on Static Lung Volumes and Exercise Endurance in COPD
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to demonstrate that treatment with a free combination
of tiotropium and salmeterol provides superior improvement in static lung volumes and
exercise tolerance compared to a fixed combination of fluticasone and salmeterol in patients
with COPD.
The secondary objective includes assessment of safety.
Phase:
Phase 4
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Fluticasone Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Fluticasone-Salmeterol Drug Combination Salmeterol Xinafoate Tiotropium Bromide